Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in Splenic Marginal Zone Lymphoma

Table 1

Clinical features at presentation in 18 cases of SMZL.

Median age, y (range)	74 (56–85)
Sex, male/female	13/5
Splenomegaly yes/no	11/7
Lymphadenopathy (yes/no)	1/14
>40% lymphs in the BM aspirate	11/4
Lymphocytosis ≥5 × 10^9/L yes/no	11/7
Absolute lymphocyte count (×10^9/L)	0.68–31.49; (median 6,63)
Villous lymphocytes yes/no	6/9
Hb < 12 g/dL yes/no	5/13; (8.6–15.2)
Platelet count ≤100 × 10^9/L yes/no	4/14; (52–239)
CD5 expression yes/no	5/13